Dr. Asim Iqbal is the Co-founder & CEO of Tibbling Technologies, where he leads the Artificial Intelligence division. With a Master's and Ph.D.
in Machine Learning and Computational Neuroscience from the Univeristy & ETH Zürich, Dr. Iqbal brings extensive expertise in developing
innovative Multimodal AI systems for healthcare applications.
Dr. Iqbal also holds the position of Adjunct Assistant Professor at Weill Cornell Medicine in New York and has previously worked as a Machine
Learning Scientist at Google X, Cajal Neuroscience, EPFL, and IBM Research.
At Tibbling Technologies, Dr. Iqbal leads a team of Ph.D. scientists
and engineers, collaborating with renowned institutions like the Broad Institute and Harvard Medical School to develop cutting-edge AI products for healthcare applications. His research work is published in top AI venues, including Nature Machine Intelligence and CVPR.
Education
Postdoctoral Research Scientist
MS-PhD. Machine Learning
Experience
Burke Neurological Institute, Weil Cornell Medicine, New York
2023-Present
Multimodal AI for neurological treatments
Cajal Neuroscience, Seattle, Washington
2021-2022
For discovering novel solutions for neurodegenerative disorders through Ai-based drug discovery
X - The Moonshot Factory, Mountain View, California
2019-2020
Project Amber - Neuro Moonshot for mental health
Allen Brain Institute and University of Washington, Seattle, WA
Summer 2018
Decoding neural population through AI - Best Project Award
IBM Research-Almaden, San Jose, California
Summer 2016
Brain-inspired algorithms on neuromorphic (TrueNorth) chip
Massachusetts Institute of Technology, Cambridge, MA
2015-2016
NeuroAI algorithms mapping with mammalian visual cortex